MX2010006987A - Composiciones topicas que contienen destiobiotin y sus derivados y un metodo de tratamiento para la piel. - Google Patents

Composiciones topicas que contienen destiobiotin y sus derivados y un metodo de tratamiento para la piel.

Info

Publication number
MX2010006987A
MX2010006987A MX2010006987A MX2010006987A MX2010006987A MX 2010006987 A MX2010006987 A MX 2010006987A MX 2010006987 A MX2010006987 A MX 2010006987A MX 2010006987 A MX2010006987 A MX 2010006987A MX 2010006987 A MX2010006987 A MX 2010006987A
Authority
MX
Mexico
Prior art keywords
desthiobiotin
topical compositions
derivatives
compositions containing
treating skin
Prior art date
Application number
MX2010006987A
Other languages
English (en)
Inventor
Xiaochun Lou
Dmitri S Ptchelintsev
Siming W Chen
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of MX2010006987A publication Critical patent/MX2010006987A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se divulgan composiciones que comprenden un sistema de gel hecho a partir de la combinación de una red fractal de nanoparticulas y partículas macroscópicas translúcidas, dióxido de titanio y otros pigmentos de color. Las composiciones son capaces de formar una película efectiva sobre una superficie biológica como la piel para atenuar las líneas de expresión y arrugas mientras se mantiene la apariencia natural de la piel como consecuencia de una sinergia entre las partículas fractales, las partículas macroscópicas, dióxido de titanio y pigmentos de color. También se divulgan métodos para su uso.
MX2010006987A 2007-12-21 2008-11-19 Composiciones topicas que contienen destiobiotin y sus derivados y un metodo de tratamiento para la piel. MX2010006987A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1570307P 2007-12-21 2007-12-21
PCT/US2008/084005 WO2009085443A1 (en) 2007-12-21 2008-11-19 Topical compositions containing desthiobiotin and its derivatives and a method of treating skin

Publications (1)

Publication Number Publication Date
MX2010006987A true MX2010006987A (es) 2010-08-18

Family

ID=40824627

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010006987A MX2010006987A (es) 2007-12-21 2008-11-19 Composiciones topicas que contienen destiobiotin y sus derivados y un metodo de tratamiento para la piel.

Country Status (10)

Country Link
US (1) US8450353B2 (es)
EP (1) EP2229137A4 (es)
JP (2) JP2011507866A (es)
CN (1) CN101903009B (es)
AR (1) AR069527A1 (es)
BR (1) BRPI0820815A2 (es)
CA (1) CA2708538C (es)
HK (1) HK1145983A1 (es)
MX (1) MX2010006987A (es)
WO (1) WO2009085443A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201021457D0 (en) * 2010-12-17 2011-02-02 Univ Manchester Anti-ageing agents
US8686013B2 (en) 2011-08-25 2014-04-01 Avon Products, Inc. Cosmetic use of substituted amino heterocylic carbamoyl analogs and related compounds
JP6032734B2 (ja) * 2012-08-24 2016-11-30 株式会社ナリス化粧品 しわ改善剤
CN102965425B (zh) * 2012-10-26 2014-10-15 上海市第十人民医院 药物筛选方法、用于促进胞外基质交联的药物及其应用
JP6120398B2 (ja) * 2012-11-02 2017-04-26 国立大学法人三重大学 水溶性フィブリリン組成物による弾性線維増強法
TW201422250A (zh) * 2012-12-11 2014-06-16 Avon Prod Inc Ｎｅｓｐｒｉｎ－２表現調節劑之用途及其組合物
JP2018158898A (ja) * 2017-03-22 2018-10-11 大阪瓦斯株式会社 トロポエラスチン発現促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2746650A1 (de) * 1977-10-17 1979-04-26 Henkel Kgaa Kosmetische mittel mit einem gehalt an haut-feuchthaltemitteln
DE2860314D1 (en) 1977-11-24 1981-02-19 Synthelabo Derivatives of naphthalene, process for their preparation and their therapeutic application
US4529587A (en) * 1982-02-19 1985-07-16 Lever Brothers Company Method of reducing sebum on the hair and skin
IT221584Z2 (it) 1991-01-25 1994-07-23 Pierottavio Canegallo Matita per uso cosmetico o da disegno
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
JP2004026743A (ja) * 2002-06-27 2004-01-29 Chisso Corp ポリリジン製剤およびこれを含有する化粧料組成物
WO2005069975A2 (en) * 2004-01-23 2005-08-04 Massachusetts Eye & Ear Infirmary Lysyl oxidase-like 1 (loxl1) and elastogenesis

Also Published As

Publication number Publication date
WO2009085443A1 (en) 2009-07-09
AR069527A1 (es) 2010-01-27
CA2708538A1 (en) 2009-07-09
BRPI0820815A2 (pt) 2016-05-10
CA2708538C (en) 2017-05-09
US20100267792A1 (en) 2010-10-21
EP2229137A4 (en) 2015-03-04
CN101903009B (zh) 2014-04-02
EP2229137A1 (en) 2010-09-22
CN101903009A (zh) 2010-12-01
JP2011507866A (ja) 2011-03-10
HK1145983A1 (en) 2011-05-13
JP6038200B2 (ja) 2016-12-07
JP2015120728A (ja) 2015-07-02
US8450353B2 (en) 2013-05-28

Similar Documents

Publication Publication Date Title
MX2010006987A (es) Composiciones topicas que contienen destiobiotin y sus derivados y un metodo de tratamiento para la piel.
MX2012013787A (es) Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel.
HK1157225A1 (en) Compositions and methods for skin care
WO2007133816A3 (en) Methods of treating pain and inflammation in neuronal tissue using il-31ra and osmrb antagonists
MX2021008610A (es) Tratamiento del cancer usando combinaciones de inhibidores de erk y raf.
MX2009005066A (es) Composiciones para mejorar la condicion y apariencia de la piel y metodos para su uso.
MX2010004074A (es) Combinacion 059.
MX363243B (es) Composiciones para tratar cáncer y usos de dichas composiciones.
HK1139863A1 (en) Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha
MX2010004877A (es) Composiciones cosmeticas de pasos multiples.
TW200602030A (en) Use of loteprednol etabonate for the treatment of dry eye
PL1919466T3 (pl) Formulacje do leczenia nieprawidłowości lipoproteinowych obejmujące statynę i pochodną metylonikotynoamidu
NO20084974L (no) Preparater og metoder for a behandle hudsykdommer kjennetegnet ved cellulaer proliferasjon og angiogenese
WO2006120681A3 (en) Compositions and methods for skin care
WO2010013110A3 (en) Composition comprising estrone and hydrocortisone for use in the topical treatment of baldness
MX2008011633A (es) Aminoquinolonas como inhibidores de gsk-3.
TR201203732T1 (tr) Opioid antagonistlerin topikal bileşimleri ve deri hastalıklarının bu bileşimler ile tedavisi için yöntemler.
WO2009079451A3 (en) Compositions and methods of promoting wound healing
WO2012050831A3 (en) Combination treatment for dermatological conditions
IL195472A0 (en) Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
WO2008070859A3 (en) Treatment of skin conditions by dickkopf1 (dkk1)
WO2012116990A3 (en) Novel use
HK1162502A1 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3
MX354383B (es) Sistemas, métodos y formulaciones para tratamiento de cáncer.
MX2008013017A (es) Tratamiento de malignidades hematologicas con fts y un inhibidor de tirosina cinasa de bcr-abl.

Legal Events

Date Code Title Description
FG Grant or registration